首页> 外文期刊>Indian drugs >FORMULATION AND EVALUATION OF MICROSPHERE BASED ORO DISPERSIBLE TABLETS OF SUMATRIPTAN SUCCINATE
【24h】

FORMULATION AND EVALUATION OF MICROSPHERE BASED ORO DISPERSIBLE TABLETS OF SUMATRIPTAN SUCCINATE

机译:微球基琥珀酸盐的微球体锻炼片的配制与评价

获取原文
获取原文并翻译 | 示例
           

摘要

Sumatriptan succinate (SS) is a drug used in the treatment of migraine headaches, but suffers from low patient compliance due to its unpalatable bitter taste. The purpose of the present work was to prepare taste-masked oro dispersible tablets (ODTs) of SS by incorporating drug loaded microspheres into tablets for use in patients experiencing difficulty in swallowing. Microspheres loaded with SS were prepared by solvent evaporation technique. Eudragit EPO, a pH-sensitive aminoaikylmethacrylate copolymer, was used for coating the drug particles, acetone as solvent for the polymer and light liquid paraffin as an encapsulating medium. Drug : polymer ratio of 1:1 was considered to be optimized formulation with a yield of 99.96%, entrapment efficiency of 61.55%, particle size ranging from 30.32 - 90.96um and in vitro drug release of 85.06% within an hour. FTIR studies suggested absence of drug-excipient interaction. Tablets prepared by direct compression containing microspheres and effervescent agents were evaluated for pre-compression and post-compression parameters. The wetting time, in vitro dispersion time and in vitro disintegration time of the tablets were found to be 39 sec, 35 sec and 32 sec, respectively. The drug release from the tablet was about 85.44% within an hour. The SEM of final ODTs revealed that the microspheres remained intact even after compression. Stability studies indicated that the selected formulation was stable. The results obtained suggested that effective taste-masking was achieved for SS using the technique of microencapsulation and ODTs of acceptable characteristics were obtained by adding effervescent agents followed by direct compression.
机译:Sumatriptan琥珀酸盐(SS)是一种用于治疗偏头痛头痛的药物,但由于其不耐益的味道,患者依从性低。本作工作的目的是通过将药物负载的微球掺入片剂中,制备SS的味道掩盖的OR分散剂片(ODTS),以用于吞咽困难的患者。通过溶剂蒸发技术制备载有SS的微球。 eudragit ePO是pH敏感的氨基酰基丙烯酸酯共聚物,用于涂覆药物颗粒,丙酮作为聚合物和轻液链烷烃作为包封介质的溶剂。药物:聚合物比为1:1被认为是优化的制剂,产率为99.96%,截留效率为61.55%,粒度范围为30.32-90.90Um,在一小时内的85.06%的体外药物释放为85.06%。 FTIR研究表明没有药物赋形剂相互作用。通过直接压制含有微球和泡腾试剂制备的片剂进行预压缩和后压缩参数。发现片剂的润湿时间,体外分散时间和体外崩解时间分别为39秒,35秒和32秒。从片剂中的药物释放在一小时内约为85.44%。最终ODTS的SEM揭示了即使在压缩后,微球仍然是完整的。稳定性研究表明所选配方稳定。得到的结果表明,使用微胶囊化技术实现了SS的有效味道,并且通过加入泡腾剂,然后直接压缩获得可接受特性的ODT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号